All publications

Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol® 888 ATO as Lipid Excipient

  • Scientific publication

Indian J Pharm Sci 2015;77(5): 620-625 - Sep 2015

Shilpa N. PATERE, Chhanda J. KAPADIA and Mangal S. NAGARSENKER

Release profile of metoprolol from sustained release tablets using Compritol® 888 ATO as SR lipid matrix agent showed high reliability. Different sources of active ingredient and batches of Compritol® were evaluated at different compression forces and in dissolution media containing or not ethanol. The formulation appeared to be very robust and is not affected by these variables. Therefore Compritol® offers great potential in the formulation of reliable SR tablets.

New insights into the stability of SR lipid matrix tablets

  • Poster

CRS Annual Meeting – Edinburgh (Scotland) - Jul 2015

Y. Rosiaux, V. Jannin, J. Doucet, J-M. Girard, F. Desvignes, and D. Marchaud

Exploring the possible relationship between the drug release of Compritol®-containing tablets and its polymorph forms using micro X-ray diffraction

  • Scientific publication

Journal of Controlled Release, Volume 197, Pages 158-164 https://doi.org/10.1016/j.jconrel.2014.11.013 - Jan 2015

Vincent Jannin; Stéphanie Chevrier; Cédric Miolane; Margaux Metin; Hamza Benhaddou; Yann Chavant; Fred Monsuur; Frédéric Demarne